On Tuesday, September 22, Antoine de Torcy, co-founder of the biotech company Biolevate, introduced the company’s innovative platform during the Trajectoire program, which was hosted by Carine Dany. The platform aims to help pharmaceutical companies bring new drugs to market faster by offering support throughout the entire drug development process, from early research to final approval and commercialization. This kind of support is crucial in an industry where bringing a new drug to patients can take over a decade and cost billions of euros. Trajectoire is a business-focused television and radio program that airs Monday through Friday on BFM Business, a French financial news channel. The show covers a range of topics related to entrepreneurship, innovation, and the economy, often featuring interviews with business leaders and experts. It provides a platform for companies to showcase their work and for investors to gain insights into emerging trends. The program is produced in partnership with Médias France, a media group that owns several television and radio stations across the country. This collaboration allows Trajectoire to reach a wider audience and maintain its position as a key source of business news and analysis in France. By featuring companies like Biolevate, the show highlights the dynamic nature of the French business landscape and the role of innovation in driving economic growth. Biolevate’s platform is part of a growing trend in the pharmaceutical industry to streamline the drug development process. With advancements in technology and a greater focus on personalized medicine, companies are increasingly looking for ways to reduce time-to-market and increase efficiency. Antoine de Torcy’s presentation during Trajectoire offers a glimpse into how Biolevate is positioning itself as a key player in this evolving sector.